No photo of Karsten Nysom

Karsten Nysom

 https://orcid.org/0000-0003-2935-0058
    1996 …2024

    Research activity per year

    Filter
    Other contribution

    Search results

    • 2024

      Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial

      Kilburn, L. B., Khuong-Quang, D.-A., Hansford, J. R., Landi, D., van der Lugt, J., Leary, S. E. S., Driever, P. H., Bailey, S., Perreault, S., McCowage, G., Waanders, A. J., Ziegler, D. S., Witt, O., Baxter, P. A., Kang, H. J., Hassall, T. E., Han, J. W., Hargrave, D., Franson, A. T. & Yalon Oren, M. & 22 others, Toledano, H., Larouche, V., Kline, C., Abdelbaki, M. S., Jabado, N., Gottardo, N. G., Gerber, N. U., Whipple, N. S., Segal, D., Chi, S. N., Oren, L., Tan, E. E. K., Mueller, S., Cornelio, I., McLeod, L., Zhao, X., Walter, A., Da Costa, D., Manley, P., Blackman, S. C., Packer, R. J. & Nysom, K., May 2024, 1 p.

      Research output: Other contribution › Communication